The p53-Mdm2 loop: a critical juncture of stress response
- PMID: 25201194
- DOI: 10.1007/978-94-017-9211-0_9
The p53-Mdm2 loop: a critical juncture of stress response
Abstract
The presence of a functional p53 protein is a key factor for the proper suppression of cancer development. A loss of p53 activity, by mutations or inhibition, is often associated with human malignancies. The p53 protein integrates various stress signals into a growth restrictive cellular response. In this way, p53 eliminates cells with a potential to become cancerous. Being a powerful decision maker, it is imperative that p53 will be activated properly, efficiently and temporarily in response to stress. Equally important is that p53 activation will be extinguished upon recovery from stress, and that improper activation of p53 will be avoided. Failure to achieve these aims is likely to have catastrophic consequences for the organism. The machinery that governs this tight regulation is largely based on the major inhibitor of p53, Mdm2, which both blocks p53 activities and promotes its destabilization. The interplay between p53 and Mdm2 involves a complex network of positive and negative feedback loops. Relief from Mdm2 suppression is required for p53 to be stabilized and activated in response to stress. Protection from Mdm2 entails a concerted action of modifying enzymes and partner proteins. The association of p53 with the PML-nuclear bodies may provide an infrastructure in which this complex regulatory network can be orchestrated. In this chapter we use examples to illustrate the regulatory machinery that drives this network.
Similar articles
-
P53 licensed to kill? Operating the assassin.J Cell Biochem. 2003 Jan 1;88(1):76-82. doi: 10.1002/jcb.10311. J Cell Biochem. 2003. PMID: 12461776 Review.
-
C-Abl as a modulator of p53.Biochem Biophys Res Commun. 2005 Jun 10;331(3):737-49. doi: 10.1016/j.bbrc.2005.03.152. Biochem Biophys Res Commun. 2005. PMID: 15865930 Review.
-
Roles for negative cell regulator 14-3-3sigma in control of MDM2 activities.Oncogene. 2007 Nov 15;26(52):7355-62. doi: 10.1038/sj.onc.1210540. Epub 2007 Jun 4. Oncogene. 2007. PMID: 17546054
-
UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.J Pathol. 2015 Mar;235(4):656-67. doi: 10.1002/path.4478. Epub 2015 Jan 7. J Pathol. 2015. PMID: 25382750
-
Oligomerization conditions Mdm2-mediated efficient p53 polyubiquitylation but not its proteasomal degradation.Int J Biochem Cell Biol. 2010 May;42(5):725-35. doi: 10.1016/j.biocel.2010.01.010. Epub 2010 Jan 18. Int J Biochem Cell Biol. 2010. PMID: 20080206
Cited by
-
TC2N: A Novel Vital Oncogene or Tumor Suppressor Gene In Cancers.Front Immunol. 2021 Dec 2;12:764749. doi: 10.3389/fimmu.2021.764749. eCollection 2021. Front Immunol. 2021. PMID: 34925334 Free PMC article. Review.
-
53BP1 and USP28 mediate p53 activation and G1 arrest after centrosome loss or extended mitotic duration.J Cell Biol. 2016 Jul 18;214(2):155-66. doi: 10.1083/jcb.201604081. J Cell Biol. 2016. PMID: 27432897 Free PMC article.
-
GINS2 regulates the proliferation and apoptosis of colon cancer cells through PTP4A1.Mol Med Rep. 2022 Apr;25(4):117. doi: 10.3892/mmr.2022.12633. Epub 2022 Feb 9. Mol Med Rep. 2022. PMID: 35137928 Free PMC article.
-
STAT1, IGF1, RAC1, and MDM2 Are Associated with Recurrence of Giant Cell Tumor of Bone.J Immunol Res. 2018 Jan 31;2018:4564328. doi: 10.1155/2018/4564328. eCollection 2018. J Immunol Res. 2018. PMID: 29651441 Free PMC article.
-
Mdm2 Splice isoforms regulate the p53/Mdm2/Mdm4 regulatory circuit via RING domain-mediated ubiquitination of p53 and Mdm4.Cell Cycle. 2017 Apr 3;16(7):660-664. doi: 10.1080/15384101.2017.1288327. Epub 2017 Feb 6. Cell Cycle. 2017. PMID: 28166445 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous